Page 215 - Liver Diseases in Children

ไวรัสตับอักเสบ 205

pthaigastro.org
12. Sridhar S, Teng JLL, Chiu TH, Lau SKP, Woo PCY. Hepatitis E virus genotypes and evolution: emergence
of camel hepatitis E variants. Int J Mol Sci 2017;18.
13. Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J. Hepatitis E pathogenesis.

Viruses 2016;8.
14. Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J. Transmission, diagnosis, and management of
hepatitis E: an update. Hepat Med 2014;6:45-59.
15. Unzueta A, Rakela J. Hepatitis E infection in liver transplant recipients. Liver Transpl 2014;20:15-24.
16. Melgaco JG, Gardinali NR, de Mello VDM, Leal M, Lewis-Ximenez LL, Pinto MA. Hepatitis E: update on
prevention and control. Biomed Res Int 2018;2018:5769201.
17. Chongsrisawat V, Poovorawan Y. Management of chronic hepatitis B and C virus infections. Indian J
Pediatr 2002;69:149-54.
18. Louisirirotchanakul S, Olinger CM, Arunkaewchaemsri P, Poovorawan Y, Kanoksinsombat C, Thongme
C, et al. The distribution of hepatitis B virus genotypes in Thailand. J Med Virol 2012;84:1541-7.
19. Chongsrisawat V, Thawornsuk N, Theamboonlers A, Louisirirotchanakul S, Poovorawan Y. Hepatitis B

virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera. Viral Immunol
2006;19:623-9.
20. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee
S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the
national expanded programme on immunization. Trop Med Int Health 2006;11:1496-502.
21. Posuwan N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, Vichaiwattana P, Klinfueng S, et al.
The success of a universal hepatitis B immunization program as part of Thailand’s EPI after 22 years’
implementation. PLoS One 2016;11:e0150499.
22. Noppornpanth S, Sathirapongsasuti N, Chongsrisawat V, Poovorawan Y. Detection of HBsAg and HBV
DNA in serum and saliva of HBV carriers. Southeast Asian J Trop Med Public Health 2000;31:419-21.
23. Coppola N, Onorato L, Minichini C, Di Caprio G, Starace M, Sagnelli C, et al. Clinical significance of
hepatitis B surface antigen mutants. World J Hepatol 2015;7:2729-39.
24. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol
2017;67:370-98.
25. Defresne F, Sokal E. Chronic hepatitis B in children: therapeutic challenges and perspectives. J

Gastroenterol Hepatol 2017;32:368-71.
26. Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, et al. Management of chronic hepatitis B
in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the
European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol 2013;59:814-29.
27. Komatsu H, Inui A, Fujisawa T. Pediatric hepatitis B treatment. Ann Transl Med 2017;5:37.
28. Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, et al. Efficacy and safety of long-term
adefovir dipivoxil therapy in children with chronic hepatitis B infection. Pediatr Infect Dis J 2012;31:578-82.